508 related articles for article (PubMed ID: 30539634)
21. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
22. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
[TBL] [Abstract][Full Text] [Related]
23. Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery.
Llinàs MC; Martínez-Edo G; Cascante A; Porcar I; Borrós S; Sánchez-García D
Drug Deliv; 2018 Nov; 25(1):1137-1146. PubMed ID: 29779394
[TBL] [Abstract][Full Text] [Related]
24. Ingenious pH-sensitive dextran/mesoporous silica nanoparticles based drug delivery systems for controlled intracellular drug release.
Zhang M; Liu J; Kuang Y; Li Q; Zheng DW; Song Q; Chen H; Chen X; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2017 May; 98():691-700. PubMed ID: 28174081
[TBL] [Abstract][Full Text] [Related]
25. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
[TBL] [Abstract][Full Text] [Related]
26. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
[TBL] [Abstract][Full Text] [Related]
27. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
28. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy.
Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C
Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118
[TBL] [Abstract][Full Text] [Related]
29. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
[TBL] [Abstract][Full Text] [Related]
30. Stepwise-acid-active organic/inorganic hybrid drug delivery system for cancer therapy.
Chen H; Chen Z; Kuang Y; Li S; Zhang M; Liu J; Sun Z; Jiang B; Chen X; Li C
Colloids Surf B Biointerfaces; 2018 Jul; 167():407-414. PubMed ID: 29704741
[TBL] [Abstract][Full Text] [Related]
31. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
[TBL] [Abstract][Full Text] [Related]
32. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
33. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
34. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
[TBL] [Abstract][Full Text] [Related]
36. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
37. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
38. Cellulose conjugated FITC-labelled mesoporous silica nanoparticles: intracellular accumulation and stimuli responsive doxorubicin release.
Hakeem A; Zahid F; Duan R; Asif M; Zhang T; Zhang Z; Cheng Y; Lou X; Xia F
Nanoscale; 2016 Mar; 8(9):5089-97. PubMed ID: 26868866
[TBL] [Abstract][Full Text] [Related]
39. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
40. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
